Investigative Urology - Results from #6380

REVIEW UroToday

A novel lily-of-the-valley fragrance contrast agent for magnetic resonance and fluorescence imaging of prostate cancer cells - Abstract February 7, 2012

Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates - Abstract February 6, 2012

Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and bak activation - Abstract February 6, 2012

GU Cancers Symposium 2012 - A phase 1 clinical trial of intravesical antisense oligonucleotide targeting heat shock protein (OGX-427) for the treatment of superficial bladder cancer - Session Highlights February 6, 2012

GU Cancers Symposium 2012 - A phase I clinical trial of intravesical antisense oligonucleotide targeting heat shock protein 27 (OGX-427) for the treatment of superficial bladder cancer - Poster February 6, 2012

Androgen receptor regulates transcription of the ZEB1 transcription factor - Abstract February 3, 2012

A novel antireflux technique for orthotopic ileal bladder substitutes-flat-segment technique: Preliminary results - Abstract February 2, 2012

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens - Abstract February 2, 2012

Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cells - Abstract February 1, 2012

Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance - Abstract January 31, 2012

Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo - Abstract January 31, 2012

N-Acyl taurines are anti-proliferative in prostate cancer cells - Abstract January 31, 2012

The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL - Abstract January 31, 2012

Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells - Abstract January 30, 2012

Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells - Abstract January 30, 2012

Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data - Abstract January 30, 2012

In vivo and in vitro effects of RAD001 on bladder cancer - Abstract January 30, 2012

Cisplatin effects on evolution of reactive oxygen species from single human bladder cancer cells investigated by scanning electrochemical microscopy - Abstract January 30, 2012

The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study - Abstract January 30, 2012

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer - Abstract January 27, 2012

Page 320 of 346